Search

Anne L. Holleran

Examiner (ID: 1384, Phone: (571)272-0833 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1643, 1642
Total Applications
775
Issued Applications
297
Pending Applications
125
Abandoned Applications
356

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6925364 [patent_doc_number] => 20050238619 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Method for the delivery of sustained release agents' [patent_app_type] => utility [patent_app_number] => 11/082851 [patent_app_country] => US [patent_app_date] => 2005-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3249 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20050238619.pdf [firstpage_image] =>[orig_patent_app_number] => 11082851 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/082851
Method for the delivery of sustained release agents Mar 17, 2005 Abandoned
Array ( [id] => 7514926 [patent_doc_number] => 08038996 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Composition and method for cancer treatment' [patent_app_type] => utility [patent_app_number] => 11/075891 [patent_app_country] => US [patent_app_date] => 2005-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 11071 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/038/08038996.pdf [firstpage_image] =>[orig_patent_app_number] => 11075891 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/075891
Composition and method for cancer treatment Mar 9, 2005 Issued
Array ( [id] => 5085335 [patent_doc_number] => 20070275386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Polymorphisms in the Epidermal Growth Factor Receptor Gene Promoter' [patent_app_type] => utility [patent_app_number] => 10/591228 [patent_app_country] => US [patent_app_date] => 2005-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17047 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275386.pdf [firstpage_image] =>[orig_patent_app_number] => 10591228 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/591228
Polymorphisms in the Epidermal Growth Factor Receptor Gene Promoter Feb 28, 2005 Abandoned
Array ( [id] => 6966022 [patent_doc_number] => 20050232919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Monoclonal antibodies that specifically block biological activity of a tumor antigen' [patent_app_type] => utility [patent_app_number] => 11/056776 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18986 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232919.pdf [firstpage_image] =>[orig_patent_app_number] => 11056776 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/056776
Monoclonal antibodies that specifically block biological activity of a tumor antigen Feb 10, 2005 Abandoned
Array ( [id] => 4443862 [patent_doc_number] => 07862817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-04 [patent_title] => 'Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies' [patent_app_type] => utility [patent_app_number] => 11/044749 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 21 [patent_no_of_words] => 36366 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/862/07862817.pdf [firstpage_image] =>[orig_patent_app_number] => 11044749 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/044749
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies Jan 26, 2005 Issued
Array ( [id] => 7136625 [patent_doc_number] => 20050181401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Reagents and methods useful for detecting diseases of the prostate' [patent_app_type] => utility [patent_app_number] => 11/043675 [patent_app_country] => US [patent_app_date] => 2005-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 37470 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181401.pdf [firstpage_image] =>[orig_patent_app_number] => 11043675 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/043675
Reagents and methods useful for detecting diseases of the prostate Jan 25, 2005 Abandoned
Array ( [id] => 8294208 [patent_doc_number] => 08221993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-17 [patent_title] => 'Methods of detecting methyl transferase activity and methods of screening for methyl transferase activity modulators' [patent_app_type] => utility [patent_app_number] => 10/586987 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 8 [patent_no_of_words] => 14575 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10586987 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586987
Methods of detecting methyl transferase activity and methods of screening for methyl transferase activity modulators Jan 20, 2005 Issued
Array ( [id] => 6996689 [patent_doc_number] => 20050136467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'ErbB4 receptor-specific neuregulin related ligands and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/035787 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 33251 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136467.pdf [firstpage_image] =>[orig_patent_app_number] => 11035787 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/035787
ErbB4 receptor-specific neuregulin related ligands and uses therefor Jan 13, 2005 Abandoned
Array ( [id] => 5085837 [patent_doc_number] => 20070275888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Preventive/Remedy for Cancer' [patent_app_type] => utility [patent_app_number] => 10/584183 [patent_app_country] => US [patent_app_date] => 2004-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44369 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275888.pdf [firstpage_image] =>[orig_patent_app_number] => 10584183 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/584183
Preventive/Remedy for Cancer Dec 23, 2004 Abandoned
Array ( [id] => 6939766 [patent_doc_number] => 20050113329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Diagnosis and treatment of malignant neoplasms' [patent_app_type] => utility [patent_app_number] => 11/020965 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18614 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113329.pdf [firstpage_image] =>[orig_patent_app_number] => 11020965 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/020965
Diagnosis and treatment of malignant neoplasms Dec 22, 2004 Abandoned
Array ( [id] => 6938557 [patent_doc_number] => 20050112120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Treatment of refractory human tumors with epidermal growth factor receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/018950 [patent_app_country] => US [patent_app_date] => 2004-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6423 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112120.pdf [firstpage_image] =>[orig_patent_app_number] => 11018950 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/018950
Treatment of refractory human tumors with epidermal growth factor receptor antagonists Dec 19, 2004 Abandoned
Array ( [id] => 7168267 [patent_doc_number] => 20050201993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase' [patent_app_type] => utility [patent_app_number] => 11/013685 [patent_app_country] => US [patent_app_date] => 2004-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 22262 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20050201993.pdf [firstpage_image] =>[orig_patent_app_number] => 11013685 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/013685
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase Dec 15, 2004 Abandoned
Array ( [id] => 5198715 [patent_doc_number] => 20070298033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Human Anti-Idiotypic Antibody Fragments that Mimic Her-2/Neu' [patent_app_type] => utility [patent_app_number] => 10/583034 [patent_app_country] => US [patent_app_date] => 2004-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11476 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20070298033.pdf [firstpage_image] =>[orig_patent_app_number] => 10583034 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/583034
Human anti-idiotypic antibody fragments that mimic HER-2/neu Dec 13, 2004 Issued
Array ( [id] => 5409565 [patent_doc_number] => 20090123463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Methods and compositions for inducing apoptosis' [patent_app_type] => utility [patent_app_number] => 10/579529 [patent_app_country] => US [patent_app_date] => 2004-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 31413 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123463.pdf [firstpage_image] =>[orig_patent_app_number] => 10579529 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/579529
Methods and compositions for inducing apoptosis Nov 16, 2004 Issued
Array ( [id] => 6906223 [patent_doc_number] => 20050101618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Selective erbB2 inhibitor/anti-erbB antibody combinations in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 10/982996 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 29566 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101618.pdf [firstpage_image] =>[orig_patent_app_number] => 10982996 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/982996
Selective erbB2 inhibitor/anti-erbB antibody combinations in the treatment of cancer Nov 3, 2004 Abandoned
Array ( [id] => 7097257 [patent_doc_number] => 20050129715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Methods and compositions for immunotherapy of cancer' [patent_app_type] => utility [patent_app_number] => 10/949667 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15183 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20050129715.pdf [firstpage_image] =>[orig_patent_app_number] => 10949667 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/949667
Methods and compositions for immunotherapy of cancer Sep 23, 2004 Issued
Array ( [id] => 7234022 [patent_doc_number] => 20050079562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin' [patent_app_type] => utility [patent_app_number] => 10/941747 [patent_app_country] => US [patent_app_date] => 2004-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7266 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079562.pdf [firstpage_image] =>[orig_patent_app_number] => 10941747 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/941747
Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin Sep 14, 2004 Issued
Array ( [id] => 4572205 [patent_doc_number] => 07858760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-28 [patent_title] => 'Antibodies to protein expressed in prostate cancer' [patent_app_type] => utility [patent_app_number] => 10/936138 [patent_app_country] => US [patent_app_date] => 2004-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 26 [patent_no_of_words] => 28008 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/858/07858760.pdf [firstpage_image] =>[orig_patent_app_number] => 10936138 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/936138
Antibodies to protein expressed in prostate cancer Sep 6, 2004 Issued
Array ( [id] => 5732763 [patent_doc_number] => 20060257880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Gastric and prostate cancer associated antigens' [patent_app_type] => utility [patent_app_number] => 10/569572 [patent_app_country] => US [patent_app_date] => 2004-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10860 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257880.pdf [firstpage_image] =>[orig_patent_app_number] => 10569572 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/569572
Gastric and prostate cancer associated antigens Aug 26, 2004 Abandoned
Array ( [id] => 5902484 [patent_doc_number] => 20060045883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Anti-cancer vaccines' [patent_app_type] => utility [patent_app_number] => 10/926852 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 66127 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20060045883.pdf [firstpage_image] =>[orig_patent_app_number] => 10926852 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/926852
Anti-cancer vaccines Aug 25, 2004 Abandoned
Menu